AZN.L - AstraZeneca PLC

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Currency in GBp

Valuation measures4

Market cap (intra-day) 182.82B
Enterprise value 202.90B
Trailing P/E 72.81
Forward P/E 20.75
PEG ratio (5-yr expected) 2.32
Price/sales (ttm)5.40
Price/book (mrq)6.43
Enterprise value/revenue 4.63
Enterprise value/EBITDA 18.42

Trading information

Stock price history

Beta (5Y monthly) 0.18
52-week change 315.87%
S&P500 52-week change 33.90%
52-week high 312,828.45
52-week low 39,399.00
50-day moving average 311,715.52
200-day moving average 311,024.78

Share statistics

Avg vol (3-month) 31.94M
Avg vol (10-day) 31.9M
Shares outstanding 51.55B
Implied shares outstanding 6N/A
Float 81.54B
% held by insiders 10.23%
% held by institutions 150.59%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.39
Forward annual dividend yield 42.05%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 30.02%
5-year average dividend yield 42.71
Payout ratio 494.50%
Dividend date 3N/A
Ex-dividend date 423 Feb 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin 10.73%
Operating margin (ttm)23.10%

Management effectiveness

Return on assets (ttm)6.43%
Return on equity (ttm)13.05%

Income statement

Revenue (ttm)43.84B
Revenue per share (ttm)28.32
Quarterly revenue growth (yoy)-4.50%
Gross profit (ttm)35.73B
EBITDA 14.89B
Net income avi to common (ttm)4.7B
Diluted EPS (ttm)2.43
Quarterly earnings growth (yoy)367.10%

Balance sheet

Total cash (mrq)6.46B
Total cash per share (mrq)4.17
Total debt (mrq)32.47B
Total debt/equity (mrq)90.68
Current ratio (mrq)0.90
Book value per share (mrq)23.10

Cash flow statement

Operating cash flow (ttm)9.71B
Levered free cash flow (ttm)9.69B